Anti-inflammatory effects of prorenin/(pro)renin receptor blockade: Potential mechanisms of action

被引：0

作者：

Nakano, Daisuke ^{[1
]}

Ichihara, Atsuhiro ^{[2
,3
]}

机构：

[1] Kagawa Univ, Dept Pharmacol, Kagawa, Japan

[2] Keio Univ, Sch Med, Dept Antiageing Med & Endocrinol, Tokyo, Japan

[3] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan

来源：

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY | 2010年 / 37卷 / 03期

关键词：

PRO RENIN RECEPTOR; HANDLE-REGION; DIABETIC-NEPHROPATHY; PRORENIN; PEPTIDE; INTERLEUKIN-6; ACTIVATION; RESPONSES; MARKERS; INJURY;

D O I：

10.1111/j.1440-1681.2009.05340.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：275 / 276

页数：2

共 26 条

[1] Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension
Crowley, Steven D.
Frey, Campbell W.
Gould, Samantha K.
Griffiths, Robert
Ruiz, Phillip
Burchette, James L.
Howell, David N.
Makhanova, Natalia
Yan, Ming
Kim, Hyung-Suk
Tharaux, Pierre-Louis
Coffman, Thomas M.
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (02) : F515 - F524
[2] The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling
Feldt, Sandra
Maschke, Ulrike
Dechend, Ralf
Luft, Friedrich C.
Muller, Dominik N.
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (04): : 743 - 748
[3] Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide
Feldt, Sandra
Batenburg, Wendy W.
Mazak, Istvan
Maschke, Ulrike
Wellner, Maren
Kvakan, Heda
Dechend, Ralf
Fiebeler, Anette
Burckle, Celine
Contrepas, Aurelie
Danser, A. H. Jan
Bader, Michael
Nguyen, Genevieve
Luft, Friedrich C.
Muller, Dominik N.
[J]. HYPERTENSION, 2008, 51 (03) : 682 - 688
[4] HUMAN PRORENIN
HSUEH, WA
BAXTER, JD
[J]. HYPERTENSION, 1991, 17 (04) : 469 - 479
[5] Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms
Huang, Y
Wongamorntham, S
Kasting, J
McQuillan, D
Owens, RT
Yu, L
Noble, NA
Border, W
[J]. KIDNEY INTERNATIONAL, 2006, 69 (01) : 105 - 113
[6] Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle'' region for nonproteolytic activation of prorenin
Ichihara, A
Hayashi, M
Kaneshiro, Y
Suzuki, F
Nakagawa, T
Tada, Y
Koura, Y
Nishiyama, A
Okada, H
Uddin, MN
Nabi, AHMN
Ishida, Y
Inagami, T
Saruta, T
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (08) : 1128 - 1135
[7] Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage
Ichihara, Atsuhiro
Kaneshiro, Yuki
Takemitsu, Tomoko
Sakoda, Mariyo
Nakagawa, Tsutomu
Nishiyama, Akira
Kawachi, Hiroshi
Shimizu, Fujio
Inagami, Tadashi
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09): : 2495 - 2503
[8] Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice
Ichihara, Atsuhiro
Suzuki, Fumiaki
Nakagawa, Tsutomu
Kaneshiro, Yuki
Takemitsu, Tomoko
Sakoda, Mariyo
Nabi, A. H. M. Nurun
Nishiyama, Akira
Sugaya, Takeshi
Hayashi, Matsuhiko
Inagami, Tadashi
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (07): : 1950 - 1961
[9] DOES THE INTRARENAL REACTIVE OXYGEN SPECIES/ANGIOTENSINOGEN/RENIN-ANGIOTENSIN SYSTEM AXIS PLAY AN IMPORTANT ROLE IN THE PROGRESSION OF CHRONIC KIDNEY DISEASE?
Konishi, Yoshio
Imanishi, Masahito
[J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (08): : 748 - 749
[10] Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes
Lu, Lin
Pu, Li Jin
Zhang, Qi
Wang, Ling Jie
Kang, Sheng
Zhang, Rui Yan
Chen, Qiu Jing
Wang, Ji Guang
De Caterina, Raffaele
Shen, Wei Feng
[J]. ATHEROSCLEROSIS, 2009, 206 (02) : 540 - 545

← 1 2 3 →